Variant report
Variant | nsv10807 |
---|---|
Chromosome Location | chr6:29498328-29501339 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:8)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
(count:8 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR2H2-2 | chr6:29498829-29501345 | NONHSAT108525 |
2 | lnc-OR2H2-2 | chr6:29498829-29498945 | NONHSAT108527 |
3 | lnc-OR2H2-2 | chr6:29499857-29501345 | NONHSAT108527 |
4 | lnc-OR2H2-2 | chr6:29498829-29499181 | NONHSAT108528 |
5 | lnc-OR2H2-2 | chr6:29499857-29499934 | ENSG00000224582.1 |
6 | lnc-OR2H2-2 | chr6:29498829-29501345 | NONHSAT108526 |
7 | lnc-OR2H2-2 | chr6:29498829-29501345 | ENSG00000224582.1 |
8 | lnc-OR2H2-2 | chr6:29498829-29498945 | ENSG00000224582.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184027680 | chr6:29498346-29498347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs376232998 | chr6:29498378-29498379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188476965 | chr6:29498413-29498414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374394437 | chr6:29498415-29498416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs546239646 | chr6:29498419-29498420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs6908631 | chr6:29498423-29498424 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs559135610 | chr6:29498434-29498435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551613954 | chr6:29498464-29498465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571382904 | chr6:29498484-29498485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs536866416 | chr6:29498485-29498486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556788577 | chr6:29498486-29498487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1233425 | chr6:29498497-29498498 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
13 | rs368054858 | chr6:29498517-29498518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552928741 | chr6:29498528-29498529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572777735 | chr6:29498541-29498542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545072306 | chr6:29498615-29498616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564844178 | chr6:29498620-29498621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149160601 | chr6:29498664-29498665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544034170 | chr6:29498671-29498672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs373652574 | chr6:29498684-29498685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143310287 | chr6:29498703-29498704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs151299205 | chr6:29498762-29498763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559679971 | chr6:29498810-29498811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563262931 | chr6:29498816-29498817 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528513563 | chr6:29498878-29498879 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs551821634 | chr6:29498903-29498904 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs3025673 | chr6:29498975-29498976 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs530576345 | chr6:29499111-29499112 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs368726319 | chr6:29499120-29499121 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs192095061 | chr6:29499131-29499132 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs184231696 | chr6:29499138-29499139 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs188562439 | chr6:29499173-29499174 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs141752127 | chr6:29499179-29499180 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs538278139 | chr6:29499193-29499194 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs558576925 | chr6:29499202-29499203 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs372352811 | chr6:29499206-29499207 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs544365113 | chr6:29499215-29499216 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs1233423 | chr6:29499301-29499302 | Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs369219409 | chr6:29499345-29499346 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs574315248 | chr6:29499386-29499387 | Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs362546 | chr6:29499416-29499417 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
42 | rs909968 | chr6:29499505-29499506 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs528462218 | chr6:29499506-29499507 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs368817346 | chr6:29499529-29499530 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs191435119 | chr6:29499534-29499535 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs909967 | chr6:29499537-29499538 | Weak transcription Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
47 | rs147103170 | chr6:29499562-29499563 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs530892933 | chr6:29499575-29499576 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs376424527 | chr6:29499620-29499621 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs567114646 | chr6:29499621-29499622 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21509527 | CNVD |
Melanoma | 17363583 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:29497000-29515000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr6:29497200-29499000 | Weak transcription | Pancreas | Pancrea |
3 | chr6:29498800-29499400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr6:29498800-29500000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
5 | chr6:29498800-29500200 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
6 | chr6:29499000-29499400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
7 | chr6:29499000-29499600 | Enhancers | Pancreas | Pancrea |
8 | chr6:29499000-29499600 | Enhancers | NHEK | skin |